Atossa Therapeutics (ATOS) Change in Inventory (2011 - 2015)
Atossa Therapeutics (ATOS) posted quarterly Change in Inventory of -$87541.0 for Q4 2015, down 139.24% year-over-year from $223080.5 in Q4 2014, and down 349.97% quarter-over-quarter from $35020.0 in Q3 2015.
Atossa Therapeutics (ATOS) Change in Inventory (2011 - 2015) Analysis & Trends
Atossa Therapeutics (ATOS) has reported Change in Inventory for 5 consecutive years, with -$87541.0 the latest figure, recorded in Q4 2015.
- In Q4 2015, Change in Inventory fell 139.24% year-over-year to -$87541.0; the TTM figure through Sep 2016 stood at -$87541.0 (down 310.06% YoY), while the FY2015 annual figure was -$9276.0, down 200.0% from the prior year.
- Change in Inventory fell to -$87541.0 in Q4 2015 per ATOS's latest filing, from $35020.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $149946.0 in Q4 2013 and bottomed at -$92026.0 in Q4 2011.
- Historically, Change in Inventory has averaged $6271.7 across 5 years, with a median of $3993.5 in 2012.
- Annual changes were most pronounced in 2014 — Change in Inventory soared 316.29% — and 2015, when it tumbled 2149.42%.
- Atossa Therapeutics' Change in Inventory stood at -$92026.0 in 2011, then soared by 106.6% to $6077.0 in 2012, then jumped by 2367.43% to $149946.0 in 2013, then sank by 124.4% to -$36591.0 in 2014, then slumped by 139.24% to -$87541.0 in 2015.
- Business Quant data shows ATOS's Change in Inventory at -$87541.0 in Q4 2015, $35020.0 in Q3 2015, and -$39144.0 in Q2 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -280,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 135.26 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 12.97 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Atossa Therapeutics | 22.63 Mn | 22.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | -87,541.00 |
| Dec 31, 2015 | -87,541.00 |
| Sep 30, 2015 | 35,020.00 |
| Sep 30, 2015 | 35,020.00 |
| Jun 30, 2015 | -39,144.00 |
| Jun 30, 2015 | -39,144.00 |
| Mar 31, 2015 | 82,389.00 |
| Mar 31, 2015 | 82,389.00 |
| Dec 31, 2014 | -36,591.00 |
| Dec 31, 2014 | -36,591.00 |
| Sep 30, 2014 | 43,957.00 |
| Sep 30, 2014 | 43,957.00 |
| Jun 30, 2014 | 1,910.00 |
| Jun 30, 2014 | 1,910.00 |
| Dec 31, 2013 | 149,946.00 |
| Dec 31, 2013 | 149,946.00 |
| Sep 30, 2013 | -20,323.00 |
| Sep 30, 2013 | -20,323.00 |
| Jun 30, 2013 | 20,323.00 |
| Jun 30, 2013 | 20,323.00 |